Hester Biosciences Limited Share Price and Company Fundamentals
Last traded: Last Friday at 9:59 AM
Hester Biosciences Limited manufactures and trades in veterinary vaccines and health products in India and internationally. It operates through two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers vaccines for peste des petits ruminants, goat pox, brucella, lumpy skin disease, contagious bovine pleuropneumonia, and contagious caprine pleuropneumonia for cattle, buffalo, sheep, and goats; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutics, nutritional supplements, and specialised formulations to enhance animal wellness and productivity. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, grooming products, and anti-infective formulations; and healthcare products, such as immune boosters, gut health enhancers, farm hygiene, vitamins, minerals, and specialty feed supplements for critical needs comprising disease prevention, growth, and nutritional balance. Additionally, the company provides Silvectant, a hydrogen peroxide and silver nitrate solution for disinfection of poultry sheds; Hestbac, a probiotic supplement to control pathogenic bacteria; Hestflora, a combined probiotic and prebiotic formulation that supports gut health and performance; AmmoStop, a probiotic blend for odour control and respiratory comfort in poultry farms. It also offers INACTIVATED H9N2 vaccine for low pathogenic avian influenza; ICEFT RTU, a ceftiofur formulation for uterine and bacterial infections; and Inomilk Gel, an oral calcium supplement, as well as operates diagnostic labs for poultry. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Mehsana, India.
Key Metrics
PE ratio
33.56
PB ratio
5.19
Dividend yield
0.50%
Beta
0.49
Market cap
₹18.70B
Enterprise value
₹20.66B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 483 |
| Website | https://www.hester.in |
| Mailing address | Village Meda - Adraj Taluka Kadi Mehsana 384441 India |
| Phone / Fax | 91 79 2644 5107 / 91 79 2644 5105 |
Dividends
Dividend yield
0.50%
Dividend amount
₹11.00
Payout ratio
10.70%
5Y Avg. yield
-%
Hester Biosciences Limited paid ₹11.00 dividend and the ex-dividend date was 14 Jul 2026.The dividend payout ratio is 10.70%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.HESTERBIO dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Jul 2026, following are the company executives and directors listed on Hester Biosciences Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Rajiv Dinesh Gandhi B.Com | Executive CEO, MD & Executive Director | 63 | |
| Ms. Priya Rajiv Gandhi | Executive Director | 32 | |
| Mr. Ashish Dineshbhai Desai | Chief Financial Officer | 57 | |
| Mr. Vinod Mali | Company Secretary & Compliance Officer | ||
| Dr. Sulochana Shrestha | CEO of Hester Biosciences Nepal Private Limited | ||
| Dr. Upendra K. Jani | Consultant | 69 |
Profitability and management effectiveness
Profit margin
16.65%
Operating margin
29.46%
Return on assets
6.51%
Return on equity
16.56%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Hester Biosciences Limited is 18.70B and its enterprise value is 20.66B. The enterprise value to revenue ratio of HESTERBIO is 6.18. The enterprise value to EBITDA ratio of HESTERBIO is 25.30.
The HESTERBIO's stocks Beta value is 0.49 making it 51% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Hester Biosciences Limited (NSE:HESTERBIO) Frequently Asked Questions
1. What is Hester Biosciences Limited's Stock Symbol?
Hester Biosciences Limited trades on NSE under the ticker symbol "HESTERBIO".
2. What is Hester Biosciences Limited's stock price today?
One share of HESTERBIO stock can currently be purchased for approximately ₹2198.4.
3. How can I contact Hester Biosciences Limited?
Hester Biosciences Limited's mailing address is Village Meda - Adraj Taluka Kadi Mehsana 384441 India. The company can be reached via phone at 91 79 2644 5107.
4. What is Hester Biosciences Limited's official website?
The official website of Hester Biosciences Limited is https://www.hester.in.